Sessa Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Sessa Capital’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-325,000	Closed	-$13.7M	–	30
2023 Q2	$13.7M	Sell	325,000 -587,586	-64%	-$23.8M	0.19%	16
2023 Q1	$32.5M	Buy	+912,586	New	+$33.1M	1.23%	19

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Sessa Capital's SYNH Position: Q3 2023 in Review

Sessa Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 325,000 shares — an estimated $13.7M sold.

Sessa Capital first reported a position in SYNH in Q1 2023 and held it in 2 quarters. The position peaked at $32.5M in Q1 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Sessa Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Sessa Capital sold 325,000 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $13.7M.
Sessa Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2023 and held it in 2 quarters.
Sessa Capital's Syneos Health, Inc. Class A Common Stock position peaked at $32.5M in Q1 2023.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Sessa Capital's 13F filing for Q3 2023, filed 14 Nov 2023.